Home / Expertise / Intellectual Property
padlock hanging from turquoise painted wooden doors

Intellectual Property

Belgium

In today’s knowledge economy, a large part of the value of your business is based on intangible assets and goodwill. Your intellectual property plays a key role in obtaining a competitive advantage. A cohesive IP strategy, including both commercialisation and enforcement, will ensure you get maximum value from your portfolio. With 150 specialist lawyers in 33 countries, we understand your business needs and have worked with some of the best-known brands, from banks to tech and media companies, pharmaceuticals and FMCG companies. This industry-specific approach can help you realise your commercial goals.

The right brands will win the hearts and minds of your customers. The right patents will prevent others exploiting your ideas or provide a substantial barrier to market access. Copyright, know-how and designs also play a vital role. We focus on key sectors relevant to you such as lifesciences, automotive, machinery, manufacturing, consumer products, financial services and TMC. This means you get in-depth industry knowledge as well as legal expertise for the protection of your IP. If you are involved in a dispute, we can guide you through the litigation process.

Winner of the 2019 Trends Legal Award for “Best law firm in IP, IT & TMT”

Trends Legal Awards

 

Read more Read less

"Firm oriented towards practical solutions resolving the issue"

Feedback from a client, Chambers Europe, 2018

"For the areas in which we work with them, they are very strong technically and legally. They are solution-driven and cost-efficient. They are very reactive and can turn around things very quickly, and they know every trick in the book."

Feedback from a client - Chambers Europe, 2017

“Established IP practice with an impressive roster of domestic and international clients. Involved in complex trade mark, patent and copyright matters, including cancellation and infringement litigation. Core sectors of expertise include sports, media, technology and consumer goods. Clients appreciate the team's high level of client service.”

Chambers Europe, 2017

“The IP attorneys at CMS are ‘on the ball’ and ‘among Belgium’s foremost specialists in the field’.”

Legal 500, 2017
20 Mar 19
EU trade marks pre­pared for no-deal Brexit
To pre­pare for a no-deal Brexit, the UK par­lia­ment passed two stat­utory in­stru­ments re­gard­ing trade marks. These in­clude: the Trade Marks (Amend­ments etc.) (EU Exit) Reg­u­la­tions, which deal with EU trade marks (EUTM). This amend­ment was ap­proved last month;...
September 2018
101 mar­ket­ingv­ragen jur­idisch beant­woord (derde edit­ie)
June 2019
CMS In­tel­lec­tu­al Prop­erty Glob­al Bro­chure

Feed

Show only
20/11/2019
CMS wins Trends Leg­al Award for "Best Bel­gian Law Firm...
03 Feb 20
SkyKick: Good news for brand own­ers - the CJEU's rul­ing main­tains...
Sum­mary The eagerly awaited judg­ment in the SkyKick case (C-371/18) was pub­lished on Wed­nes­day. The case relates to ques­tions re­ferred to the CJEU by the UK High Court in trade mark in­fringe­ment pro­ceed­ings...
June 2019
CMS In­tel­lec­tu­al Prop­erty Glob­al Bro­chure
31 Jan 20
UK In­tel­lec­tu­al Prop­erty Of­fice finds that pat­ent law does not cater...
The UK In­tel­lec­tu­al Prop­erty Of­fice has found that DABUS is not a per­son and so can­not be con­sidered an in­vent­or of a pat­ent. DABUS is an ar­ti­fi­cial in­tel­li­gence (AI) ma­chine. The UKIPO ac­cep­ted the in­dic­a­tion...
02/04/2019
European Uni­on Trade Mark Reg­u­la­tion and Com­munity...
A Com­ment­ary
31 Jan 20
A Short Guide: Pri­or­ity En­ti­tle­ment at the EPO
Art­icle 87 EPC Pri­or­ity right (1) Any per­son who has duly filed, in or for (a) any State party to the Par­is Con­ven­tion for the Pro­tec­tion of In­dus­tri­al Prop­erty or (b) any Mem­ber of the World Trade Or­gan­iz­a­tion,...
30/11/2018
Novem­ber 2018 News­let­ter
15 Jan 20
Can newly dis­covered can­nabis com­pounds be pro­tec­ted by pat­ents?
A break­through dis­cov­ery has re­cently hit the news: tet­rahy­drocan­nabi­phorol (THCP) and can­na­bid­i­phorol (CB­DP), two new can­nabin­oid com­pounds, have been dis­covered in Can­nabis sativa and char­ac­ter­ised...
22/06/2018
June 2018 News­let­ter
20 Dec 19
‘Dar­unavir’ CJEU re­fer­ral with­drawn - Art­icle 3(a) of the SPC Reg­u­la­tion
At the end of Septem­ber, we re­por­ted here on the pub­lic­a­tion of AG Hogan’s Opin­ion on the joint re­fer­rals from the Ger­man Bundes­pat­ent­gericht (case C-650/17) for Mer­ck’s sitaglipt­in product and from...
16/03/2018
March 2018 News­let­ter
17 Dec 19
The rise of pat­ent wars in Europe’s gene ther­apy space
The gene ther­apy in­dustry is in an ex­cit­ing phase of growth, un­der­go­ing sig­ni­fic­ant M&A activ­ity, product sales and new mar­ket­ing au­thor­isa­tions that are be­ing is­sued with in­creas­ing reg­u­lar­ity glob­ally....